BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/11/2026 11:23:54 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-12-10 00:44 |
|
Peer-Review Started |
|
2025-12-10 08:31 |
|
First Decision by Editorial Office Director |
|
2026-01-06 06:35 |
|
Return for Revision |
|
2026-01-06 06:35 |
|
Revised |
|
2026-01-17 12:48 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-02-06 02:50 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-06 08:56 |
|
Articles in Press |
|
2026-02-06 08:56 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-06-03 15:30 |
|
Publish the Manuscript Online |
|
2026-06-11 11:23 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Correspondence |
| Article Title |
Letter to the Editor: Akkermansia muciniphila serves as an immunomodulator for type 1 diabetes mellitus: Promises and pitfalls
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ying Qian, Jun Xu, Jun-Min Wang, Xing-Li Wu and Yi-Yuan Zheng |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yi-Yuan Zheng, Laboratory Center, Department of Gastroenterology, Shanghai Municipal Hospital of Traditional Chinese Medicine, No. 274 Zhijiang Middle Road, Shanghai 200071, China. iceroser@126.com |
| Key Words |
Type 1 diabetes mellitus; Akkermansia muciniphila; Immunomodulator; Gut microbiota; Clinical application |
| Core Tip |
This article offers a critical evaluation of the therapeutic potential of Akkermansia muciniphila in the context of type 1 diabetes mellitus. While the study has yielded promising results in terms of immunomodulatory effects, the absence of metabolic reversal highlights significant challenges in translating these findings into clinical applications. This article emphasizes the need for caution regarding the inhibition of immune pathways, interspecies variability, and potential ecological trade-offs within the gut microbiome. Future investigations should prioritize clinical trials and combination therapies to realize its therapeutic potential in type 1 diabetes mellitus. |
| Publish Date |
2026-06-11 11:23 |
| Citation |
Qian Y, Xu J, Wang JM, Wu XL, Zheng YY. Letter to the Editor: Akkermansia muciniphila serves as an immunomodulator for type 1 diabetes mellitus: Promises and pitfalls. World J Diabetes 2026; 17(6): 117542
|
| URL |
https://www.wjgnet.com/1948-9358/full/v17/i6/117542.htm |
| DOI |
https://doi.org/10.4239/wjd.117542 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
